trending Market Intelligence /marketintelligence/en/news-insights/trending/ukjkiocyzm6htkqhlxojbg2 content esgSubNav
In This List

Integra LifeSciences plans common stock offering to reduce debt

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Integra LifeSciences plans common stock offering to reduce debt

Integra LifeSciences Holdings Corp. is planning a public offering of 5,250,000 common shares.

The Plainsboro, N.J.-based surgical implant maker intends to grant the underwriters a 30-day option to buy an additional 787,500 common shares.

Integra plans to use net proceeds to buy additional shares, to cut outstanding revolving borrowings under its senior credit facility.

J.P. Morgan and Wells Fargo Securities will be joint book-running managers for the offering.